|
US2003199A
(en)
|
1930-05-31 |
1935-05-28 |
Johnson Frank James |
Automatic coal stoker
|
|
US2003149A
(en)
|
1931-05-22 |
1935-05-28 |
Autographic Register Co |
Manifolding
|
|
US2003065A
(en)
|
1931-06-20 |
1935-05-28 |
John R Ditmars |
Composition for coating sheets, fibrous stocks, and the like
|
|
US2004102A
(en)
|
1932-02-24 |
1935-06-11 |
Daniel A Dickey |
Hollow steel propeller construction
|
|
US2004138A
(en)
|
1932-11-30 |
1935-06-11 |
Byers A M Co |
Method of making wrought iron pipe
|
|
US2002165A
(en)
|
1933-07-08 |
1935-05-21 |
Charles A Winslow |
Air cleaner
|
|
US2003187A
(en)
|
1933-10-02 |
1935-05-28 |
Frederick H Shaw |
Automobile radio device
|
|
US2003166A
(en)
|
1933-10-26 |
1935-05-28 |
Zancan Ottavio |
Front drive for motor cars
|
|
US2001051A
(en)
|
1933-12-01 |
1935-05-14 |
Angelina Mariani |
Tamperproof meter box with cutout control and fuse drawer for electric meters
|
|
US2004092A
(en)
|
1933-12-15 |
1935-06-11 |
John L Chaney |
Device for indicating the temperature of liquids
|
|
US2003060A
(en)
|
1934-04-02 |
1935-05-28 |
Ernest L Heckert |
Thermostatic controlling device
|
|
US2667486A
(en)
|
1951-05-24 |
1954-01-26 |
Research Corp |
2,4-diamino pteridine and derivatives
|
|
IL44058A
(en)
|
1973-02-02 |
1978-10-31 |
Ciba Geigy Ag |
3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
|
|
AU535258B2
(en)
|
1979-08-31 |
1984-03-08 |
Ici Australia Limited |
Benzotriazines
|
|
DE3205638A1
(de)
|
1982-02-17 |
1983-08-25 |
Hoechst Ag, 6230 Frankfurt |
Trisubstituierte pyrimidin-5-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
|
US4490289A
(en)
|
1982-09-16 |
1984-12-25 |
Hoffmann-La Roche Inc. |
Homogeneous human interleukin 2
|
|
US5616584A
(en)
|
1986-09-25 |
1997-04-01 |
Sri International |
1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
|
|
JP2598100B2
(ja)
|
1988-08-31 |
1997-04-09 |
キヤノン株式会社 |
電子写真感光体
|
|
US5214059A
(en)
|
1989-07-03 |
1993-05-25 |
Hoechst-Roussel Pharmaceuticals Incorporated |
2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
|
|
US5776502A
(en)
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
|
US5041430A
(en)
*
|
1989-09-18 |
1991-08-20 |
Du Pont Mereck Pharmaceutical Company |
Oral anticoagulant/platelet inhibitor low dose formulation
|
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
Ｎ―（１ｈ―テトラゾール―５―イル）―２―アニリノ―５―ピリミジンカルボキシアミド類及びその合成中間体
|
|
GB9003553D0
(en)
|
1990-02-16 |
1990-04-11 |
Ici Plc |
Herbicidal compositions
|
|
JP2839106B2
(ja)
|
1990-02-19 |
1998-12-16 |
キヤノン株式会社 |
電子写真感光体
|
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
|
MY107955A
(en)
|
1990-07-27 |
1996-07-15 |
Ici Plc |
Fungicides.
|
|
GB9016800D0
(en)
|
1990-07-31 |
1990-09-12 |
Shell Int Research |
Tetrahydropyrimidine derivatives
|
|
DE4025891A1
(de)
|
1990-08-16 |
1992-02-20 |
Bayer Ag |
Pyrimidyl-substituierte acrylsaeureester
|
|
JPH05345780A
(ja)
|
1991-12-24 |
1993-12-27 |
Kumiai Chem Ind Co Ltd |
ピリミジンまたはトリアジン誘導体及び除草剤
|
|
HUT63941A
(en)
|
1992-05-15 |
1993-11-29 |
Hoechst Ag |
Process for producing 4-alkyl-substituted pyrimidine-5-carboxanilide derivatives, and fungicidal compositions comprising same
|
|
US5438130A
(en)
|
1993-01-15 |
1995-08-01 |
Cambridge Neuroscience, Inc. |
Fucosylated guanosine disulfates as excitatory amino acid antagonists
|
|
JPH0741461A
(ja)
|
1993-05-27 |
1995-02-10 |
Eisai Co Ltd |
スルホン酸エステル誘導体
|
|
JPH0782183A
(ja)
|
1993-09-09 |
1995-03-28 |
Canon Inc |
液晶中間体化合物、液晶性化合物、高分子液晶化合物、高分子液晶共重合体化合物、それらの組成物、液晶素子および記録装置
|
|
DE4338704A1
(de)
|
1993-11-12 |
1995-05-18 |
Hoechst Ag |
Stabilisierte Oligonucleotide und deren Verwendung
|
|
US5530000A
(en)
|
1993-12-22 |
1996-06-25 |
Ortho Pharmaceutical Corporation |
Substituted pyrimidinylaminothiazole derivatives useful as platelet aggreggation inhibitors
|
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
|
US5597826A
(en)
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
|
DE19502912A1
(de)
|
1995-01-31 |
1996-08-01 |
Hoechst Ag |
G-Cap Stabilisierte Oligonucleotide
|
|
US6326487B1
(en)
|
1995-06-05 |
2001-12-04 |
Aventis Pharma Deutschland Gmbh |
3 modified oligonucleotide derivatives
|
|
AU726522B2
(en)
|
1995-09-01 |
2000-11-09 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
WO1997024122A1
(en)
|
1995-12-29 |
1997-07-10 |
Smithkline Beecham Corporation |
Vitronectin receptor antagonists
|
|
JPH09274290A
(ja)
|
1996-02-07 |
1997-10-21 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料用の現像液および処理方法
|
|
WO1997030707A1
(en)
|
1996-02-23 |
1997-08-28 |
Eli Lilly And Company |
NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS
|
|
DE59707681D1
(de)
|
1996-10-28 |
2002-08-14 |
Rolic Ag Zug |
Vernetzbare, photoaktive Silanderivate
|
|
WO1998022588A2
(en)
|
1996-11-20 |
1998-05-28 |
Introgen Therapeutics, Inc. |
An improved method for the production and purification of adenoviral vectors
|
|
JP3734903B2
(ja)
|
1996-11-21 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
|
JPH10153838A
(ja)
|
1996-11-22 |
1998-06-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JP3720931B2
(ja)
|
1996-11-26 |
2005-11-30 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
US5935383A
(en)
|
1996-12-04 |
1999-08-10 |
Kimberly-Clark Worldwide, Inc. |
Method for improved wet strength paper
|
|
WO1998024974A1
(en)
|
1996-12-04 |
1998-06-11 |
Kimberly-Clark Worldwide, Inc. |
Method for making wet strength paper
|
|
DE69720773T2
(de)
|
1996-12-23 |
2004-01-29 |
Bristol Myers Squibb Pharma Co |
SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER
|
|
JPH10207019A
(ja)
|
1997-01-22 |
1998-08-07 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
|
DE59807348D1
(de)
|
1997-02-05 |
2003-04-10 |
Rolic Ag Zug |
Photovernetzbare Silanderivate
|
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JPH10260512A
(ja)
|
1997-03-19 |
1998-09-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料の処理方法
|
|
JPH10310583A
(ja)
|
1997-05-09 |
1998-11-24 |
Mitsubishi Chem Corp |
ピリドンアゾ系化合物、感熱転写用色素およびそれを使用した感熱転写材料
|
|
US6070126A
(en)
|
1997-06-13 |
2000-05-30 |
William J. Kokolus |
Immunobiologically-active linear peptides and method of identification
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
US6635626B1
(en)
|
1997-08-25 |
2003-10-21 |
Bristol-Myers Squibb Co. |
Imidazoquinoxaline protein tyrosine kinase inhibitors
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
EP1054004B1
(en)
|
1997-12-15 |
2008-07-16 |
Astellas Pharma Inc. |
Novel pyrimidine-5-carboxamide derivatives
|
|
EP1042299A1
(en)
|
1997-12-22 |
2000-10-11 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
|
EA200000840A1
(ru)
|
1998-02-17 |
2001-02-26 |
Туларик, Инк. |
Антивирусные производные пиримидина
|
|
EA002973B1
(ru)
|
1998-03-27 |
2002-12-26 |
Янссен Фармацевтика Н.В. |
Производные пиримидина в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
KR100643419B1
(ko)
|
1998-03-27 |
2006-11-10 |
얀센 파마슈티카 엔.브이. |
Ｈｉｖ를 억제하는 피리미딘 유도체
|
|
US6685938B1
(en)
|
1998-05-29 |
2004-02-03 |
The Scripps Research Institute |
Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases
|
|
DE19830181C1
(de)
|
1998-07-06 |
1999-09-30 |
Inter Control Koehler Hermann |
Mehrpolige elektrische Steckverbindung
|
|
US6136971A
(en)
|
1998-07-17 |
2000-10-24 |
Roche Colorado Corporation |
Preparation of sulfonamides
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
IL142092A0
(en)
|
1998-09-29 |
2002-03-10 |
American Cyanamid Co |
Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
|
|
ATE255575T1
(de)
|
1998-09-29 |
2003-12-15 |
Wyeth Corp |
Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
|
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
US6288082B1
(en)
|
1998-09-29 |
2001-09-11 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
AU2871900A
(en)
|
1999-02-04 |
2000-08-25 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
|
EP1169038B9
(en)
|
1999-04-15 |
2013-07-10 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
ES2216884T3
(es)
|
1999-04-21 |
2004-11-01 |
Wyeth Holdings Corporation |
3-ciano-(1.7),(1.5) y (1.8)-naftiridina sustituidas que son inhibidores de tirosina-quinasas.
|
|
WO2000071536A1
(en)
|
1999-05-20 |
2000-11-30 |
E.I. Du Pont De Nemours And Company |
Heteroaryloxypyrimidine insecticides and acaricides
|
|
US6710221B1
(en)
|
1999-06-15 |
2004-03-23 |
Kimberly-Clark Worldwide, Inc. |
Absorbent articles incorporating color change graphics
|
|
BR0012046A
(pt)
|
1999-07-01 |
2002-05-14 |
Ajinomoto Kk |
Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
|
|
WO2001007027A2
(en)
|
1999-07-22 |
2001-02-01 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives for the treatment of viral diseases
|
|
BR0012697A
(pt)
|
1999-07-23 |
2002-04-09 |
Shionogi & Co |
Inibidores da diferenciação de th2
|
|
WO2001007401A1
(en)
|
1999-07-23 |
2001-02-01 |
Shionogi & Co., Ltd. |
Tricyclic compounds and drug compositions containing the same
|
|
HUP0203162A3
(en)
|
1999-08-12 |
2006-07-28 |
Wyeth Holdings Corp Madison |
Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AU779908B2
(en)
|
1999-09-10 |
2005-02-17 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
WO2001027105A1
(en)
|
1999-10-12 |
2001-04-19 |
Takeda Chemical Industries, Ltd. |
Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
|
|
EP1226123A1
(en)
|
1999-11-03 |
2002-07-31 |
Du Pont Pharmaceuticals Company |
Cyano compounds as factor xa inhibitors
|
|
GB9929988D0
(en)
|
1999-12-17 |
2000-02-09 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DK1242382T3
(da)
|
1999-12-29 |
2007-05-07 |
Wyeth Corp |
Tricycliske proteinkinaseinhibitorer
|
|
US6638929B2
(en)
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
|
WO2001055116A2
(en)
|
2000-01-28 |
2001-08-02 |
Astrazeneca Ab |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
|
US6153752A
(en)
|
2000-01-28 |
2000-11-28 |
Creanova, Inc. |
Process for preparing heterocycles
|
|
US20020165244A1
(en)
|
2000-01-31 |
2002-11-07 |
Yuhong Zhou |
Mucin synthesis inhibitors
|
|
AU3704101A
(en)
|
2000-02-17 |
2001-08-27 |
Amgen Inc |
Kinase inhibitors
|
|
IL150895A0
(en)
|
2000-02-18 |
2003-02-12 |
Teva Pharma |
Oral, nasal and pulmonary formulations of copolymer-1
|
|
WO2001062233A2
(en)
|
2000-02-25 |
2001-08-30 |
F. Hoffmann La Roche Ag |
Adenosine receptor modulators
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
JP2003525291A
(ja)
|
2000-03-01 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
２，４−二置換チアゾリル誘導体
|
|
US6605615B2
(en)
|
2000-03-01 |
2003-08-12 |
Tularik Inc. |
Hydrazones and analogs as cholesterol lowering agents
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
JP2001247411A
(ja)
|
2000-03-09 |
2001-09-11 |
Tomono Agrica Co Ltd |
有害生物防除剤
|
|
CN1190197C
(zh)
|
2000-03-13 |
2005-02-23 |
惠氏控股公司 |
氰基喹啉用于制备治疗或抑制结肠息肉药物中的用途
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
KR20030009416A
(ko)
|
2000-04-04 |
2003-01-29 |
시오노기세이야쿠가부시키가이샤 |
고지용성 약물을 함유하는 유성 조성물
|
|
AU2001244610A1
(en)
|
2000-04-05 |
2001-10-23 |
Shionogi And Co., Ltd. |
Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
|
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
|
DE10024622A1
(de)
|
2000-05-18 |
2001-11-22 |
Piesteritz Stickstoff |
N-(2-Pyrimidinyl)(thio)phosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse
|
|
US6875483B2
(en)
|
2000-07-06 |
2005-04-05 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and alignment promoter
|
|
WO2002014319A2
(en)
|
2000-08-11 |
2002-02-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
AU2002213467A8
(en)
|
2000-10-11 |
2009-07-30 |
Chemocentryx Inc |
Modulation of ccr4 function
|
|
US7067532B2
(en)
|
2000-11-02 |
2006-06-27 |
Astrazeneca |
Substituted quinolines as antitumor agents
|
|
EP1337513A1
(en)
|
2000-11-02 |
2003-08-27 |
AstraZeneca AB |
4-substituted quinolines as antitumor agents
|
|
MXPA03004458A
(es)
|
2000-11-20 |
2005-01-25 |
Pharmacia Corp |
Arilpiridinas y heteroarilpiridinas sustituidas utiles para inhibicion selectiva de la cascada de coagulacion.
|
|
US20070026433A1
(en)
*
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
|
AU2002232919A1
(en)
|
2000-12-29 |
2002-07-16 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
|
JP2002221770A
(ja)
|
2001-01-24 |
2002-08-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料およびその処理方法
|
|
AU2002258400A1
(en)
|
2001-02-16 |
2002-08-28 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
PL364625A1
(en)
|
2001-02-23 |
2004-12-13 |
Merck & Co, Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
EP1370250A2
(en)
|
2001-03-23 |
2003-12-17 |
Chugai Seiyaku Kabushiki Kaisha |
Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
|
|
AU2002338642A1
(en)
|
2001-04-13 |
2002-10-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
US20040157866A1
(en)
|
2001-04-30 |
2004-08-12 |
Hisashi Takasugi |
Amide compounds
|
|
WO2002092087A1
(en)
|
2001-05-11 |
2002-11-21 |
Vertex Pharmaceuticals Incorporated |
2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
|
|
WO2002094766A1
(en)
|
2001-05-18 |
2002-11-28 |
Nihon Nohyaku Co., Ltd. |
Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
|
|
WO2002096903A2
(fr)
|
2001-05-28 |
2002-12-05 |
Aventis Pharma S.A. |
Derives chimiques et leur application comme agent antitelomerase
|
|
BR0209774A
(pt)
|
2001-05-29 |
2004-06-01 |
Schering Ag |
Pirimidinas inibidoras de cdk, sua preparação e aplicação como medicamento
|
|
RU2294192C2
(ru)
|
2001-05-30 |
2007-02-27 |
Дзе Скриппс Рисерч Инститьют |
Система доставки нуклеиновых кислот
|
|
ES2274035T3
(es)
|
2001-06-01 |
2007-05-16 |
Vertex Pharmaceuticals Incorporated |
Compuestos de tiazol utiles como inhibidores de proteina quinasas.
|
|
ATE337312T1
(de)
|
2001-07-03 |
2006-09-15 |
Vertex Pharma |
Isoxazolyl-pyrimidines als inhibitoren von src- und lck-protein-kinasen
|
|
US6861529B2
(en)
|
2001-07-06 |
2005-03-01 |
Pfizer Inc |
Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
|
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
|
CN101851173A
(zh)
|
2001-09-14 |
2010-10-06 |
梅特希尔基因公司 |
组蛋白脱乙酰化酶抑制剂
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
DE10150615A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte
|
|
DE10150610A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Amidbasen
|
|
DE10150614A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
HUP0402106A3
(en)
|
2001-11-01 |
2009-07-28 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
ES2294190T3
(es)
|
2001-11-01 |
2008-04-01 |
Janssen Pharmaceutica N.V. |
Derivados de amida como inhibidores de la glucogeno sintasa quinasa 3-beta.
|
|
AR037438A1
(es)
|
2001-11-27 |
2004-11-10 |
Wyeth Corp |
3-cianoquinolinas como inhibidores de egf-r y her2 quinasas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos
|
|
US20050038035A1
(en)
|
2001-11-28 |
2005-02-17 |
Hisashi Takasugi |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
IL162838A0
(en)
|
2002-01-04 |
2005-11-20 |
Univ Rockefeller |
Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
BR0307375A
(pt)
|
2002-02-05 |
2004-12-07 |
Wyeth Corp |
Processo para a sìntese de ácidos n-acil-2-amino-4-alcóxi-5-nitro-benzóicos
|
|
AU2003209077A1
(en)
|
2002-02-08 |
2003-09-02 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
AU2003220970A1
(en)
|
2002-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
WO2003095448A1
(en)
|
2002-05-06 |
2003-11-20 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
EP1539899B1
(en)
|
2002-07-02 |
2008-12-17 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric adhesive compositions and laminates
|
|
US7361665B2
(en)
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
|
HRP20050089B1
(hr)
|
2002-07-29 |
2015-06-19 |
Rigel Pharmaceuticals |
Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
|
|
MXPA05001277A
(es)
|
2002-08-02 |
2005-10-06 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
DE10240261A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
DE10240262A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Aryllithium-Basen
|
|
AU2003282726B2
(en)
|
2002-10-03 |
2010-10-07 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US20050282814A1
(en)
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US20060167021A1
(en)
|
2002-10-04 |
2006-07-27 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Inhibition of src for treatment of reperfusion injury related to revascularization
|
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
|
AU2003286711A1
(en)
|
2002-10-25 |
2004-05-13 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7259161B2
(en)
|
2002-11-04 |
2007-08-21 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
US20050101576A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
WO2004052373A1
(en)
|
2002-12-06 |
2004-06-24 |
Warner-Lambert Company Llc |
Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
|
|
JP3837670B2
(ja)
|
2002-12-12 |
2006-10-25 |
富士通株式会社 |
データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
JP2006514050A
(ja)
|
2002-12-20 |
2006-04-27 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニスト誘導体としてのβ−アミノ酸化合物のＲ異性体
|
|
EP1592421A1
(en)
|
2002-12-20 |
2005-11-09 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
WO2004058782A1
(en)
|
2002-12-24 |
2004-07-15 |
Astrazeneca Ab |
Therapeutic quinazoline derivatives
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
BRPI0407329A
(pt)
|
2003-02-07 |
2006-01-10 |
Janssen Pharmaceutica Nv |
Derivados de pirimidina para a prevenção de infecção de hiv
|
|
HRP20050690A2
(en)
|
2003-02-07 |
2006-08-31 |
Janssen Pharmaceutica N.V. |
Hiv inhibiting 1,2,4-triazines
|
|
EP1594512A4
(en)
|
2003-02-11 |
2007-07-11 |
Kemia Inc |
COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
CL2004000306A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
CA2559670A1
(en)
|
2003-04-14 |
2004-10-28 |
Gabor Pragai |
Stable amlodipine maleate formulations
|
|
US20040265375A1
(en)
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
|
JP5047613B2
(ja)
|
2003-04-24 |
2012-10-10 |
クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ |
ヒドロゲルコンタクトレンズ及び包装システム及びそれらの製造方法
|
|
WO2005012294A1
(en)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
PT1660458E
(pt)
|
2003-08-15 |
2012-04-27 |
Novartis Ag |
2,4-pirimidinodiaminas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
US20070105839A1
(en)
|
2003-09-18 |
2007-05-10 |
Patricia Imbach |
2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
US7652051B2
(en)
|
2004-08-25 |
2010-01-26 |
Targegen, Inc. |
Heterocyclic compounds and methods of use
|
|
US7210697B2
(en)
|
2004-12-16 |
2007-05-01 |
Tricam International, Inc. |
Convertible handle
|
|
ATE519759T1
(de)
|
2004-12-30 |
2011-08-15 |
Exelixis Inc |
Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren
|
|
GT200600008A
(es)
*
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
JP2008533166A
(ja)
|
2005-03-16 |
2008-08-21 |
ターゲジェン インコーポレーティッド |
ピリミジン化合物および使用法
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
AU2006254825A1
(en)
|
2005-06-08 |
2006-12-14 |
Targegen, Inc. |
Methods and compositions for the treatment of ocular disorders
|
|
BRPI0610876B8
(pt)
|
2005-06-08 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, formulação farmacêutica, e métodos de inibir uma atividade de uma jak cinase, e de inibir uma cascata de transdução de sinal em que jak3 cinase desempenha um papel
|
|
KR100848205B1
(ko)
|
2005-06-20 |
2008-07-24 |
주식회사 동부하이텍 |
면역 억제 및 염증 억제 활성을 갖는 신규한 치환된1,3-티아졸 유도체 또는 이의 약학적으로 허용가능한 염,중간체 화합물 또는 이의 약학적으로 허용가능한 염, 이의제조방법, 및 이를 포함하는 약학적 조성물
|
|
WO2007000778A2
(en)
|
2005-06-29 |
2007-01-04 |
Panacea Biotec Ltd. |
Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
CA2621261C
(en)
|
2005-09-22 |
2014-05-20 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
US20070072682A1
(en)
|
2005-09-29 |
2007-03-29 |
Crawford James T Iii |
Head to head electronic poker game assembly and method of operation
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
JP5191391B2
(ja)
*
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
WO2007056075A2
(en)
|
2005-11-02 |
2007-05-18 |
Targegen, Inc. |
Six membered heteroaromatic inhibitors targeting resistant kinase mutations
|
|
US7803806B2
(en)
|
2005-11-03 |
2010-09-28 |
Sgx Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
|
WO2007069274A2
(en)
|
2005-11-09 |
2007-06-21 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
|
|
WO2007058627A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Oxygen linked pyrimidine derivatives
|
|
SG10202003901UA
(en)
|
2005-12-13 |
2020-05-28 |
Incyte Holdings Corp |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
|
|
KR20080110998A
(ko)
*
|
2006-01-30 |
2008-12-22 |
엑셀리시스, 인코포레이티드 |
Ｊａｋ２ 조절자로서 ４아릴２아미노피리미딘 또는 4아릴２아미노알킬피리미딘 및 이들을 포함하는 약제학적 조성물
|
|
ES2622493T3
(es)
|
2006-02-24 |
2017-07-06 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
|
KR101784001B1
(ko)
|
2006-04-04 |
2017-10-23 |
케이지 액퀴지션 엘엘씨 |
항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물
|
|
US7691858B2
(en)
|
2006-04-25 |
2010-04-06 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
EP2037918A2
(en)
*
|
2006-05-15 |
2009-03-25 |
Acadia Pharmaceuticals Inc. |
Pharmaceutical formulations of pimavanserin
|
|
WO2008008234A1
(en)
|
2006-07-07 |
2008-01-17 |
Targegen, Inc. |
2-amino-5-substituted pyrimidine inhibitors
|
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
|
WO2008009458A1
(en)
|
2006-07-21 |
2008-01-24 |
Novartis Ag |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
WO2008057233A2
(en)
*
|
2006-10-25 |
2008-05-15 |
The Regents Of The University Of California |
Models of erythropoiesis
|
|
KR20150036210A
(ko)
|
2007-06-13 |
2015-04-07 |
인사이트 코포레이션 |
야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
|
|
DE102007034947B4
(de)
*
|
2007-07-26 |
2009-06-18 |
Siemens Ag |
Vorrichtung zum Entladen eines Stapels von auf ihren Schmalseiten stehenden flachen Gegenständen
|
|
CN101802182A
(zh)
*
|
2007-08-21 |
2010-08-11 |
诺达利蒂公司 |
用于诊断、预后和治疗方法的方法
|
|
WO2009046416A1
(en)
|
2007-10-05 |
2009-04-09 |
Targegen Inc. |
Anilinopyrimidines as jak kinase inhibitors
|
|
AU2009271129B2
(en)
*
|
2008-07-14 |
2013-10-10 |
Otonomy, Inc. |
Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
|
|
AU2009279825A1
(en)
|
2008-08-05 |
2010-02-11 |
Targegen, Inc. |
Methods of treating thalassemia
|
|
DK2376500T3
(en)
|
2008-12-11 |
2015-05-04 |
Cti Biopharma Corp |
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaenmaleatsalt
|
|
ES2382773T3
(es)
|
2009-03-13 |
2012-06-13 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Composiciones de ezetimiba
|
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
|
US20100297194A1
(en)
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
|
JP2013500949A
(ja)
|
2009-07-31 |
2013-01-10 |
ビーエーエスエフ ソシエタス・ヨーロピア |
イミダゾール基含有ホスフィンボラン化合物とイミダゾール基含有ホスフィンボラン化合物の製造方法
|
|
US20120157500A1
(en)
|
2009-08-24 |
2012-06-21 |
Weikang Tao |
Jak inhibition blocks rna interference associated toxicities
|
|
AU2010363329A1
(en)
*
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
TW201316989A
(zh)
|
2011-07-21 |
2013-05-01 |
Sanofi Sa |
用於治療真性多血症及原發性血小板過多症之組合物及方法
|
|
WO2013059548A1
(en)
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|